|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
53,543,000 |
Market
Cap: |
11.50(B) |
Last
Volume: |
464,634 |
Avg
Vol: |
475,567 |
52
Week Range: |
$164.52 - $273.43 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 400 MIDCAP |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 456 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments include: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; Manufacturing Support, which ensure the safe production and release of products manufactured by Co.'s clients.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
7,942 |
11,192 |
Total Buy Value |
$0 |
$0 |
$1,447,725 |
$2,162,353 |
Total People Bought |
0 |
0 |
3 |
3 |
Total Buy Transactions |
0 |
0 |
3 |
5 |
Total Shares Sold |
1,636 |
31,084 |
49,996 |
92,833 |
Total Sell Value |
$374,194 |
$7,621,206 |
$11,292,577 |
$21,658,880 |
Total People Sold |
2 |
6 |
6 |
8 |
Total Sell Transactions |
2 |
11 |
16 |
28 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Girshick Birgit |
Corporate Executive VP & COO |
|
2023-11-20 |
4 |
B |
$187.82 |
$248,298 |
D/D |
1,322 |
44,449 |
2.74 |
37% |
|
Foster James C |
Chairman, President and CEO |
|
2023-11-14 |
4 |
B |
$178.05 |
$1,000,641 |
D/D |
5,620 |
202,643 |
2.81 |
49% |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2023-11-09 |
4 |
S |
$172.77 |
$1,583,522 |
D/D |
(9,128) |
24,983 |
|
-61% |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2023-11-09 |
4 |
OE |
$144.67 |
$1,320,548 |
D/D |
9,128 |
34,111 |
|
- |
|
Wallman Richard F |
Director |
|
2023-08-24 |
4 |
B |
$198.79 |
$198,786 |
I/I |
1,000 |
1,000 |
2.1 |
13% |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2023-08-10 |
4 |
S |
$216.54 |
$318,530 |
D/D |
(1,471) |
9,940 |
|
-5% |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2023-08-10 |
4 |
OE |
$144.67 |
$212,810 |
D/D |
1,471 |
11,411 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2023-08-10 |
4 |
OE |
$144.67 |
$797,276 |
D/D |
5,511 |
9,103 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2023-08-10 |
4 |
S |
$217.24 |
$1,251,954 |
D/D |
(5,763) |
3,592 |
|
-5% |
|
Foster James C |
Chairman, President and CEO |
|
2023-08-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,500 |
197,023 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2023-08-10 |
4 |
S |
$216.52 |
$151,564 |
D/D |
(700) |
24,983 |
|
-5% |
|
Mackay Martin |
Director |
|
2023-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
95 |
11,600 |
|
- |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,528 |
9,940 |
|
- |
|
Mackay Martin |
Director |
|
2023-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
338 |
11,505 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2023-05-29 |
4 |
D |
$194.12 |
$43,289 |
D/D |
(223) |
25,683 |
|
- |
|
Girshick Birgit |
Corporate Executive VP & COO |
|
2023-05-29 |
4 |
D |
$194.12 |
$41,930 |
D/D |
(216) |
43,477 |
|
- |
|
Creamer Victoria L |
EVP & Chief People Officer |
|
2023-05-29 |
4 |
D |
$194.12 |
$36,883 |
D/D |
(190) |
16,506 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2023-05-29 |
4 |
D |
$194.12 |
$247,309 |
D/D |
(1,274) |
199,523 |
|
- |
|
Parisotto Shannon M |
CEVP, Disc & Safety Assessment |
|
2023-05-29 |
4 |
D |
$194.12 |
$21,353 |
D/D |
(110) |
7,288 |
|
- |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2023-05-29 |
4 |
D |
$194.12 |
$6,988 |
D/D |
(36) |
8,412 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2023-05-29 |
4 |
D |
$194.12 |
$39,212 |
D/D |
(202) |
9,954 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2023-05-28 |
4 |
D |
$194.12 |
$24,265 |
D/D |
(125) |
25,906 |
|
- |
|
Girshick Birgit |
Corporate Executive VP & COO |
|
2023-05-28 |
4 |
D |
$194.12 |
$25,624 |
D/D |
(132) |
43,693 |
|
- |
|
Creamer Victoria L |
EVP & Chief People Officer |
|
2023-05-28 |
4 |
D |
$194.12 |
$22,324 |
D/D |
(115) |
16,696 |
|
- |
|
Parisotto Shannon M |
CEVP, Disc & Safety Assessment |
|
2023-05-28 |
4 |
D |
$194.12 |
$13,783 |
D/D |
(71) |
7,398 |
|
- |
|
1166 Records found
|
|
Page 3 of 47 |
|
|